The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches ...
The agency found Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.
Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized brand on Jan. 16.
Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Nicotine pouch use grew in popularity during the survey period, as 24.7% of soldiers queried in 2023 reported using nicotine pouches compared with 20.2% in 2022.
Nicotine pouch use grew in popularity during the survey period, as 24.7% of soldiers queried in 2023 reported using nicotine pouches compared with 20.2% in 2022.